Enrique J. Andreu

3.6k total citations
46 papers, 2.4k citations indexed

About

Enrique J. Andreu is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Enrique J. Andreu has authored 46 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Enrique J. Andreu's work include Mesenchymal stem cell research (13 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Tissue Engineering and Regenerative Medicine (7 papers). Enrique J. Andreu is often cited by papers focused on Mesenchymal stem cell research (13 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Tissue Engineering and Regenerative Medicine (7 papers). Enrique J. Andreu collaborates with scholars based in Spain, United States and Belgium. Enrique J. Andreu's co-authors include Felipe Prósper, José L. Fernández-Luna, Cristina Arbona, Fermín Sánchez‐Guijo, Cristina Sanz, Adalberto Benito, Eva M. Villarón, Pablo Aranda, Josè Antonio Pérez-Simón and José A. Martínez-Climent and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Enrique J. Andreu

45 papers receiving 2.3k citations

Peers

Enrique J. Andreu
Reiner Class United States
Enrique J. Andreu
Citations per year, relative to Enrique J. Andreu Enrique J. Andreu (= 1×) peers Reiner Class

Countries citing papers authored by Enrique J. Andreu

Since Specialization
Citations

This map shows the geographic impact of Enrique J. Andreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique J. Andreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique J. Andreu more than expected).

Fields of papers citing papers by Enrique J. Andreu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique J. Andreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique J. Andreu. The network helps show where Enrique J. Andreu may publish in the future.

Co-authorship network of co-authors of Enrique J. Andreu

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique J. Andreu. A scholar is included among the top collaborators of Enrique J. Andreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique J. Andreu. Enrique J. Andreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andreu, Enrique J., et al.. (2023). Upstream conduct and price authority with competing organizations. Journal of Economics & Management Strategy. 32(4). 788–810.
2.
Andreu, Enrique J., Damien Neven, & Salvatore Piccolo. (2023). Price authority and information sharing with competing supply chains. International Journal of Industrial Organization. 88. 102926–102926. 3 indexed citations
3.
Cerio, Ascensión López-Dı́az de, Susana Inogés, Gloria Abizanda, et al.. (2021). Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics. 13(8). 1269–1269. 4 indexed citations
4.
Campo, Arantza, Enrique J. Andreu, Ana B. Alcaide, et al.. (2021). Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial. ERJ Open Research. 7(2). 773–2020. 20 indexed citations
5.
Lamo-Espinosa, José María, Juan F. Blanco, Mikel Sánchez, et al.. (2020). Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis. Journal of Translational Medicine. 18(1). 356–356. 84 indexed citations
6.
Inogés, Susana, Sonia Tejada, Ascensión López-Dı́az de Cerio, et al.. (2017). A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients. Journal of Translational Medicine. 15(1). 104–104. 109 indexed citations
7.
Lamo-Espinosa, José María, Gonzalo Mora, Juan F. Blanco, et al.. (2016). Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II). Journal of Translational Medicine. 14(1). 246–246. 244 indexed citations
8.
Rodríguez-Diaz, Saray, Manuel Mazo, Gloria Abizanda, et al.. (2015). Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue. Stem Cell Research. 16(1). 20–23. 11 indexed citations
9.
Llufriú, Sara, María Sepúlveda, Yolanda Blanco, et al.. (2014). Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis. PLoS ONE. 9(12). e113936–e113936. 123 indexed citations
10.
Pérez-Simón, Josè Antonio, Olga López‐Villar, Enrique J. Andreu, et al.. (2011). Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica. 96(7). 1072–1076. 136 indexed citations
11.
Andreu, Enrique J., Carmen Ivorra, Enric Poch, et al.. (2010). Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells. Oncogene. 29(22). 3276–3286. 21 indexed citations
12.
Pérez-Ilzarbe, M., María Díez‐Campelo, Pablo Aranda, et al.. (2009). Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion. 49(9). 1901–1910. 83 indexed citations
13.
Aranda, Pablo, Xabier Agirre, Esteban Ballestar, et al.. (2009). Epigenetic Signatures Associated with Different Levels of Differentiation Potential in Human Stem Cells. PLoS ONE. 4(11). e7809–e7809. 82 indexed citations
14.
Pérez-Ilzarbe, M., Onnik Agbulut, Beatriz Pelacho, et al.. (2008). Characterization of the Paracrine Effects of Human Skeletal Myoblasts Transplanted in Infarcted Myocardium. European Journal of Heart Failure. 10(11). 1065–1072. 111 indexed citations
15.
Montiel‐Duarte, Cristina, Lucía Cordeu, Xabier Agirre, et al.. (2008). Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leukemia Research. 32(5). 709–716. 33 indexed citations
16.
José‐Eneriz, Edurne San, José Román‐Gómez, Lucía Cordeu, et al.. (2008). BCR‐ABL1‐induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia. British Journal of Haematology. 142(4). 571–582. 31 indexed citations
17.
Llano, José Javier Martı́n de, Graciela Fuertes, Enrique J. Andreu, et al.. (2006). A single point mutation in the low-density lipoprotein receptor switches the degradation of its mature protein from the proteasome to the lysosome. The International Journal of Biochemistry & Cell Biology. 38(8). 1340–1351. 13 indexed citations
18.
Agirre, Xabier, José Román‐Gómez, Iria Vázquez, et al.. (2005). Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib. Cancer Genetics and Cytogenetics. 160(1). 22–26. 10 indexed citations
19.
Sanz, Cristina, et al.. (2001). Antiapoptotic protein Bcl-xL is up-regulated during megakaryocytic differentiation of CD34+ progenitors but is absent from senescent megakaryocytes. Experimental Hematology. 29(6). 728–735. 42 indexed citations
20.
Andreu, Enrique J., Adalberto Benito, Cristina Arbona, et al.. (2000). Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL. The Journal of Experimental Medicine. 191(6). 977–984. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026